UK consensus statement on the use of plerixafor to facilitate autologous peripheral blood stem cell collection to support high‐dose chemoradiotherapy for patients with malignancy
Kenneth Douglas(Beatson West of Scotland Cancer Centre), Keith Wilson(Cardiff University), Ram Malladi(Cambridge University Hospitals NHS Foundation Trust), John A. Snowden(Sheffield Teaching Hospitals NHS Foundation Trust), Nigel H. Russell(Guy's and St Thomas' NHS Foundation Trust), Charlotte Kallmeyer(Lincoln County Hospital), Mike Watts(Inspira Medical Center Vineland), Hannah Hunter(Derriford Hospital), Maria Gilleece(Leeds Teaching Hospitals NHS Trust), Kavita Raj(Johns Hopkins Hospital), Rachel Pawson(NHS Blood and Transplant), Eleni Tholouli(Manchester Royal Infirmary), Anna Sureda(Institut d'Investigació Biomédica de Bellvitge), Stephen Robinson(University of Sussex), Peter Johnson(Western General Hospital), Deborah Richardson(University Hospital Southampton NHS Foundation Trust), Kirsty Thomson(University College Hospital), Patrick Hayden, Shankara Paneesha(University of Leeds), Michael Quinn(Queen's University Belfast)
Cited by 50
Related Papers
Axicabtagene Ciloleucel as Second-Line Therapy for Large B-Cell Lymphoma
|New England Journal of Medicine|2021|1.6k
Guidelines for the diagnosis and management of adult aplastic anaemia
|British Journal of Haematology|2015|750
Glofitamab for Relapsed or Refractory Diffuse Large B-Cell Lymphoma
|New England Journal of Medicine|2022|718